Cargando…

Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients

BACKGROUND: Immune checkpoint inhibitors have achieved unprecedented success in cancer immunotherapy. With the exception of a few candidate biomarkers, the prognostic role of soluble immune checkpoint-related proteins in clear cell renal cell cancer (ccRCC) patients is largely uninvestigated. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qinchuan, Zhang, Jinhua, Tu, Huakang, Liang, Dong, Chang, David. W., Ye, Yuanqing, Wu, Xifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884764/ https://www.ncbi.nlm.nih.gov/pubmed/31783776 http://dx.doi.org/10.1186/s40425-019-0810-y

Ejemplares similares

Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer
por: Wang, Qinchuan, et al.
Publicado: (2022)

Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study
por: Wang, Qinchuan, et al.
Publicado: (2020)

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer
por: Wang, Qinchuan, et al.
Publicado: (2020)

Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins
por: Pan, Sai, et al.
Publicado: (2023)

Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types
por: Tu, Huakang, et al.
Publicado: (2022)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
por: Choi, Y, et al.
Publicado: (2013)

Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
por: Arai, Eri, et al.
Publicado: (2015)

Development and verification of a nomogram for prediction of recurrence‐free survival in clear cell renal cell carcinoma
por: Chen, Yuanlei, et al.
Publicado: (2019)

Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
por: Masuda, Akinori, et al.
Publicado: (2014)

Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery
por: El-Mokadem, I, et al.
Publicado: (2014)

Overexpression of Spondin-2 Is Associated with Recurrence-Free Survival in Patients with Localized Clear Cell Renal Cell Carcinoma
por: Ma, Hui-Min, et al.
Publicado: (2020)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

A Contemporary Review of Immune Checkpoint Inhibitors in Advanced Clear Cell Renal Cell Carcinoma
por: Yu, Eun-mi, et al.
Publicado: (2021)

Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience
por: Barua, Sasanka Kumar, et al.
Publicado: (2019)

Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
por: Larrinaga, Gorka, et al.
Publicado: (2021)

Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities
por: Zarrabi, Kevin, et al.
Publicado: (2021)

Preoperative Butyrylcholinesterase Level as an Independent Predictor of Overall Survival in Clear Cell Renal Cell Carcinoma Patients Treated with Nephrectomy
por: Koie, Takuya, et al.
Publicado: (2014)

Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
por: Möller, Katharina, et al.
Publicado: (2021)

Body mass index and survival after cancer diagnosis: A pan-cancer cohort study of 114 430 patients with cancer
por: Tu, Huakang, et al.
Publicado: (2022)

Influence of gene expression on survival of clear cell renal cell carcinoma
por: Berglund, Anders, et al.
Publicado: (2020)

Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma
por: Fang, Yuan, et al.
Publicado: (2019)

Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe
por: Malicki, Stanisław, et al.
Publicado: (2022)

A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
por: Palma dos Reis, Ana Filipa, et al.
Publicado: (2022)

Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade
por: Yoshida, Takashi, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
por: Fan, ZhiXiang, et al.
Publicado: (2022)

Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Lee, Ji Hyun, et al.
Publicado: (2023)

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
por: Zhang, Haijian, et al.
Publicado: (2017)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Synchronous Metastatic Clear Cell Renal Cell Carcinoma to the Gallbladder With Metachronous Contralateral Recurrence
por: Pierce, Daniel P, et al.
Publicado: (2021)

Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
por: Ivanova, Elizaveta, et al.
Publicado: (2023)

The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response
por: Wang, Chang, et al.
Publicado: (2023)

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection
por: Fu, Qiang, et al.
Publicado: (2014)

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
por: Wang, Zewei, et al.
Publicado: (2016)

Development of an Interferon Gamma Response-Related Signature for Prediction of Survival in Clear Cell Renal Cell Carcinoma
por: Liu, Lixiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rj8qars2j9tbjrvl5knmtch4qf